Removal kinetics of therapeutic apheresis

Blood Transfusion

Volumn 5, Issue 3, 2007, Pages 164-174

  Reverberi, Roberto ^a,b   Reverberi, Lorenzo ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b Servizio di Immunoematologia e Trasfusionale Arcispedale SAnna   (Italy)

Author keywords

Plasma exchange; Removal kinetics; Sickle cell anaemia; Therapeutic apheresis

Indexed keywords

APHERESIS; ARTICLE; CLINICAL FEATURE; ERYTHROCYTE; EXCHANGE BLOOD TRANSFUSION; FLOW KINETICS; MATHEMATICAL MODEL; PLASMA VOLUME; PLASMAPHERESIS; THROMBOCYTOPHERESIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 47749108687     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2007.0032-07     Document Type: Article

References (35)

1. Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998; 339:1578-84.
2. Rock GA. Management of thrombotic thrombocytopenic purpura. Br J Haematol 2000; 109: 496-507.
3. Reverberi R, Reverberi L. Removal kinetics of exchange transfusion. Blood Transfusion 2007; 5: 93-101.
4. McLeod BC (editor). Special issue: Clinical applications of therapeutic apheresis. J Clin Apheresis 2000; 15:1-159.
5. Kaplan AA. A Practical Guide to Therapeutic Plasma Exchange. Malden, MA, Blackwell Science, 1999.
6. Waldmann TA, Strober W. Metabolism of immunoglobulins. In Kallos P, Waksman BH editors: Progress in Allergy, New York: S. Karger AG; 1969. (Cit. in ref. )
7. Volkin RL, Starz TW, Winkelstein A, et al. Changes in coagulation factors, complement, immunoglobulins, and immune complex concentrations with plasma exchange. Transfusion 1982; 22: 54-8.
8. Orlin JB, Berkman EM. Partial plasma exchange using albumin replacement: removal and recovery of normal plasma constituents. Blood 1980; 56:1055-9.
9. Greenough A. Rhesus disease: postnatal management and outcome. Eur J Pediatr 1999; 158: 689-93.
10. Magosso E, Ursino M, Colì L, et al. A modeling study of bilirubin kinetics during molecular adsorbent recirculating system sessions. Artif Organs 2006; 30: 285-300.
11. Wiener AS, Wexler IB. The use of heparin when performing exchange blood transfusions in newborn infants. J Lab Clin Med 1946; 31:1016-9.
12. Kellogg RM, Hester JP. Kinetics modeling of plasma exchange: Intra- and post-plasma exchange. J Clin Apheresis 1988; 4:183-7.
13. Klein HG. Principles of apheresis. In Anderson KC, Ness PM, editors: Scientific Basis of Transfusion Medicine, Philadelphia PA: WB Saunders; 1994. p. 781-96.
14. Sprenger KBG, Huber K, Kratz W, et al. Nomograms for the prediction of patient's plasma volume in plasma exchange therapy from height, weight, and hematocrit. J Clin Apheresis 1987; 3:185-90.
15. Matic G, Hofmann D, Winkler R, et al. Removal of immunoglobulins by a protein A versus an antihuman immunoglobulin G-based system: evaluation of 602 sessions of extracorporeal immunoadsorption. Artif Organs 2000; 24:103-7.
16. Depner AT. Catheter performance. Semin Dial 2001; 14: 425-31.
17. Hershko AY, Naparstek Y. Removal of pathogenic autoantibodies by immunoadsorption. Ann N Y Acad Sci 2005; 1051: 635-46.
18. Beck JR, Quinn BM, Meier FA, et al. Hyperviscosity syndrome in paraproteinemia. Managed by plasma exchange; monitored by serum tests. Transfusion 1982; 22: 51-3.
19. Yeh JH, Chen WH, Chiu HC. Predicting the course of myasthenic weakness following double filtration plasmapheresis. Acta Neurol Scand 2003; 108:174-8.
20. Volkin RL, Starz TW, Winkelstein A, et al. Changes in coagulation factors, complement, immunoglobulins, and immune complex concentrations with plasma exchange. Transfusion 1982; 22: 54-8.
21. Filomena CA, Filomena AP, Hudock J, et al. Evaluation of serum immunoglobulins by protein electrophoresis and rate nephelometry before and after therapeutic plasma exchange. Am J Clin Pathol 1992; 98:243-8.
22. Schindhelm K, Charlton B, Antony G, et al. Antibody kinetics following extracorporeal removal. In Smeby LC, Jørstad S, Widerøe T-E (editors): Immune and Metabolic Aspects of Therapeutic Blood Purification Systems, Basel: S Karger; 1986. p.329-37.
23. Harvey GK, Schindhelm K, Antony JH, et al. Membrane plasma exchange in experimental allergic neuritis: effect on antibody levels and clinical course. J Neurol Sci 1988; 88: 207-18.
24. Harvey GK, Schindhelm K, Pollard JD. IgG immunoadsorption in experimental allergic neuritis: effect on antibody levels and clinical course. J Neurol Neurosurg Psychiatry 1989; 52: 865-70.
25. Knöbl P, Haas M, Laczika K, et al. Immunoadsorption for the treatment of a patient with severe thrombotic thrombocytopenic purpura resistant to plasma exchange: kinetics of an inhibitor of ADAMTS13. J Thromb Haemost 2003; 1: 187-9 (letter).
26. Dau PC. Immunologic rebound. J Clin Apheresis 1995; 10: 210-7.
27. Dau PC. The fundamental basis for therapeutic plasmapheresis in autoimmune diseases. Transfus Sci 1996; 17: 235-44.
28. Derksen RHWM, Schuurman HJ, Gmelig Meyling FHJ. Rebound and overshoot after plasma exchange in humans. J Lab Clin Med 1984; 104: 35-43.
29. Wallace DJ, Goldfinger D, Pepkowitz SH, et al. Randomized controlled trial of pulse/synchronization cyclophosphamide/apheresis for proliferative lupus nephritis. J Clin Apheresis 1998; 13: 163-6.
30. Danielson CFM. The role of red blood cell exchange transfusion in the treatment and prevention of complications of sickle cell disease. Ther Apher 2002; 6: 24-31.
31. Weir EG, King KE, Ness PM, Eshleman SH. Automated RBC exchange transfusion: treatment for cerebral malaria. Transfusion 2000; 40: 702-7.
32. Kim HC, Dugan NP, Silber JH, et al. Erythrocytapheresis therapy to reduce iron overload in chronically transfused patients with sickle cell disease. Blood 1994; 83: 1136-42.
33. Janes SL, Pocock M, Bishop E, et al. Automated red cell exchange in sickle cell disease. Br J Haematol 1997; 97: 256-8.
34. Nifong TP, Bongiovanni MB, Gerhard GS. Mathematical modelling and computer simulation of erythrocytapheresis for SCD. Transfusion 2001; 41: 256-63.
35. th ed. Philadelphia, PA, Lippincott Williams & Wilkins, 2003.